VEGF Receptor 2 (VEGFR2) (N-Term) Peptide
VEGFR2
适用: 人
宿主: 合成
BP, IHC, WB
-
- 抗原 See all VEGFR2/CD309 (VEGFR2) products
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- 蛋白结构域
- N-Term
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-KDR antibody (Catalog #: AVARP20010_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
- 背景
-
KDR is the receptor for VEGF or VEGFC. It has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions.
Alias Symbols: CD309, FLK1, VEGFR, VEGFR2
Protein Interaction Partner: SHC2,VEGFA,VEGFA,VEGFA,VEGFC,ACP1,ANXA5,ATR,BMX,CAV1,CBL,CDH5,COL18A1,CRK,CSF2RB,CTNNB1,DNM2,FIGF,FLT1,FLT4,FRS2,FYN,GNA11,GNAQ,GRB10,GRB2,HSP90AA1,IQGAP1,ITGB3,KDR,NCK1,NRP1,P2RY2,PLCG1,PLCG2,PTPN11,PTPN6,RASA1,SH2D2A,SHB,SHC1,SHC2,SRC,STAT1,SYNGAP1,TIMP3,VEGFA,VEGFC,YES1,ACP1,ANXA5,CBL,CDH5,COL18A1,FIGF,FLT1,GRB10,GRB2,PLCG1,PLXNA1,RASA1,SHB,SHC1,SHC2,VEGFA
Protein Size: 1356 - 分子量
- 151 kDa
- 基因ID
- 3791
- NCBI登录号
- NM_002253, NP_002244
- UniProt
- P35968
-
You are here:
